Family · Pharmaceutical analytical standards
Imipenem
A very broad-spectrum beta-lactam antibiotic of the carbapenem family, developed in the mid-1970s and approved in 1985 for serious infections; it is given with cilastatin, which stops the kidneys from breaking it down. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It derives from thienamycin, made by the soil bacterium Streptomyces cattleya: too unstable in water to become a medicine, it was turned into imipenem after lengthy trial and error.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
